Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04204057
Brief Title: Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

First Submitted : December 4, 2019
First Submitted that Met QC Criteria : December 16, 2019
First Posted : December 18, 2019

Results First Submitted : July 2, 2021
Results First Submitted that Met QC Criteria : July 2, 2021
Results First Posted : July 22, 2021

Last Update Submitted that Met QC Criteria : July 22, 2021
Last Update Posted : July 23, 2021